DK0880524T3 - Adenosine antagonists, processes for their preparation and their use as drugs - Google Patents
Adenosine antagonists, processes for their preparation and their use as drugsInfo
- Publication number
- DK0880524T3 DK0880524T3 DK97933683T DK97933683T DK0880524T3 DK 0880524 T3 DK0880524 T3 DK 0880524T3 DK 97933683 T DK97933683 T DK 97933683T DK 97933683 T DK97933683 T DK 97933683T DK 0880524 T3 DK0880524 T3 DK 0880524T3
- Authority
- DK
- Denmark
- Prior art keywords
- drugs
- processes
- preparation
- adenosine antagonists
- adenosine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychology (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19629378A DE19629378A1 (en) | 1996-07-20 | 1996-07-20 | New triazolopurines, process for their preparation and their use as medicaments |
| PCT/EP1997/003841 WO1998003511A1 (en) | 1996-07-20 | 1997-07-17 | New triazolopurines, method of preparing them and their use as drugs |
| CA002242097A CA2242097C (en) | 1996-07-20 | 1998-06-26 | Imidazotriazolopyrimidines, process for preparing them and their use as pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0880524T3 true DK0880524T3 (en) | 2000-07-17 |
Family
ID=32963000
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK97933683T DK0880524T3 (en) | 1996-07-20 | 1997-07-17 | Adenosine antagonists, processes for their preparation and their use as drugs |
Country Status (25)
| Country | Link |
|---|---|
| EP (2) | EP0880524B1 (en) |
| JP (1) | JP3020281B2 (en) |
| CN (1) | CN1219936A (en) |
| AT (1) | ATE191913T1 (en) |
| AU (1) | AU3695597A (en) |
| BG (1) | BG102707A (en) |
| BR (1) | BR9710747A (en) |
| CA (1) | CA2256736A1 (en) |
| CZ (1) | CZ265498A3 (en) |
| DE (2) | DE19629378A1 (en) |
| DK (1) | DK0880524T3 (en) |
| EE (1) | EE9800451A (en) |
| ES (1) | ES2147453T3 (en) |
| GR (1) | GR3033842T3 (en) |
| HR (1) | HRP970395A2 (en) |
| HU (1) | HUP9902311A3 (en) |
| ID (1) | ID19106A (en) |
| IL (1) | IL126453A0 (en) |
| NO (1) | NO983860L (en) |
| PL (1) | PL328824A1 (en) |
| PT (1) | PT880524E (en) |
| SK (1) | SK114498A3 (en) |
| TR (1) | TR199801659T2 (en) |
| WO (1) | WO1998003511A1 (en) |
| ZA (1) | ZA976331B (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19826843A1 (en) * | 1998-06-16 | 1999-12-23 | Boehringer Ingelheim Pharma | Novel imidazotriazolopyrimidines, process for their preparation and their use as medicaments |
| US6492377B1 (en) | 1998-06-25 | 2002-12-10 | Boehringer Ingelheim Pharma Kg | Imidazotriazolopyrimidines with adenosine-antagonistic activity |
| AU9347498A (en) * | 1998-08-27 | 2000-03-21 | Boehringer Ingelheim Pharma Kg | Imidazotriazolopyrimidines |
| US7329668B2 (en) | 2003-02-25 | 2008-02-12 | Bristol-Myers Squibb Company | Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same |
| US7071333B2 (en) | 2003-07-30 | 2006-07-04 | Bristol-Myers Squibb Company | Triazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same |
| AR061625A1 (en) * | 2006-06-23 | 2008-09-10 | Incyte Corp | DERIVATIVES OF PURINONA AS AGONISTS OF HM74A |
| CR20230030A (en) | 2018-02-27 | 2023-03-10 | Incyte Corp | Imidazopyrimidines and triazolopyrimidines as a2a / a2b inhibitors |
| MX2020012376A (en) | 2018-05-18 | 2021-03-09 | Incyte Corp | Fused pyrimidine derivatives as a2a / a2b inhibitors. |
| MX2021000116A (en) | 2018-07-05 | 2021-03-29 | Incyte Corp | Fused pyrazine derivatives as a2a / a2b inhibitors. |
| PE20211768A1 (en) | 2018-11-30 | 2021-09-07 | Merck Sharp & Dohme | DERIVATIVES OF AMINE TRIAZOLO QUINAZOLINE 9-SUBSTITUTED AS ANTAGONISTS OF THE ADENOSINE RECEPTOR, PHARMACEUTICAL COMPOSITIONS AND THEIR USE |
| TWI829857B (en) | 2019-01-29 | 2024-01-21 | 美商英塞特公司 | Pyrazolopyridines and triazolopyridines as a2a / a2b inhibitors |
| CN112778311B (en) * | 2019-11-01 | 2024-06-04 | 上海翰森生物医药科技有限公司 | Nitrogen-containing cyclic derivative inhibitor, preparation method and application thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA902282B (en) * | 1989-03-29 | 1990-12-28 | Merrell Dow Pharma | Selective adenosine receptor compounds |
| IT1264901B1 (en) * | 1993-06-29 | 1996-10-17 | Schering Plough S P A | HETEROCYCLIC ANALOGUES OF 1,2,4-TRIAZOLE(15-C)PYRIMIDINES WITH ANTAGONIST ACTIVITY FOR THE ADENOSINE A2 RECEPTOR |
| JPH083169A (en) * | 1994-06-15 | 1996-01-09 | Yamasa Shoyu Co Ltd | 4-methyl-1h-(1,2,4)triazolo(1,5-a)purin-9(4h)-ones |
-
1996
- 1996-07-20 DE DE19629378A patent/DE19629378A1/en not_active Withdrawn
-
1997
- 1997-07-17 WO PCT/EP1997/003841 patent/WO1998003511A1/en not_active Ceased
- 1997-07-17 PL PL97328824A patent/PL328824A1/en unknown
- 1997-07-17 CZ CZ982654A patent/CZ265498A3/en unknown
- 1997-07-17 DE DE59701467T patent/DE59701467D1/en not_active Expired - Lifetime
- 1997-07-17 TR TR1998/01659T patent/TR199801659T2/en unknown
- 1997-07-17 CA CA002256736A patent/CA2256736A1/en not_active Abandoned
- 1997-07-17 CN CN97194506A patent/CN1219936A/en active Pending
- 1997-07-17 DK DK97933683T patent/DK0880524T3/en active
- 1997-07-17 EP EP97933683A patent/EP0880524B1/en not_active Expired - Lifetime
- 1997-07-17 EP EP99119410A patent/EP0978517A3/en not_active Withdrawn
- 1997-07-17 HU HU9902311A patent/HUP9902311A3/en unknown
- 1997-07-17 ZA ZA976331A patent/ZA976331B/en unknown
- 1997-07-17 AU AU36955/97A patent/AU3695597A/en not_active Abandoned
- 1997-07-17 EE EE9800451A patent/EE9800451A/en unknown
- 1997-07-17 SK SK1144-98A patent/SK114498A3/en unknown
- 1997-07-17 BR BR9710747A patent/BR9710747A/en unknown
- 1997-07-17 ES ES97933683T patent/ES2147453T3/en not_active Expired - Lifetime
- 1997-07-17 PT PT97933683T patent/PT880524E/en unknown
- 1997-07-17 IL IL12645397A patent/IL126453A0/en unknown
- 1997-07-17 AT AT97933683T patent/ATE191913T1/en active
- 1997-07-17 JP JP10505626A patent/JP3020281B2/en not_active Expired - Fee Related
- 1997-07-18 ID IDP972495A patent/ID19106A/en unknown
- 1997-07-18 HR HR19629378.2A patent/HRP970395A2/en not_active Application Discontinuation
-
1998
- 1998-08-20 BG BG102707A patent/BG102707A/en unknown
- 1998-08-21 NO NO983860A patent/NO983860L/en not_active Application Discontinuation
-
2000
- 2000-06-30 GR GR20000401543T patent/GR3033842T3/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT880524E (en) | 2000-07-31 |
| HUP9902311A3 (en) | 2000-06-28 |
| CN1219936A (en) | 1999-06-16 |
| CA2256736A1 (en) | 1998-01-29 |
| EP0978517A3 (en) | 2003-11-12 |
| IL126453A0 (en) | 1999-08-17 |
| DE59701467D1 (en) | 2000-05-25 |
| ES2147453T3 (en) | 2000-09-01 |
| HUP9902311A2 (en) | 1999-10-28 |
| TR199801659T2 (en) | 1998-12-21 |
| ATE191913T1 (en) | 2000-05-15 |
| EP0880524A1 (en) | 1998-12-02 |
| EE9800451A (en) | 1999-06-15 |
| ZA976331B (en) | 1999-01-25 |
| EP0880524B1 (en) | 2000-04-19 |
| BR9710747A (en) | 1999-08-17 |
| NO983860L (en) | 1998-10-21 |
| PL328824A1 (en) | 1999-02-15 |
| JP2000501420A (en) | 2000-02-08 |
| NO983860D0 (en) | 1998-08-21 |
| EP0978517A2 (en) | 2000-02-09 |
| ID19106A (en) | 1998-06-18 |
| CZ265498A3 (en) | 1998-12-16 |
| JP3020281B2 (en) | 2000-03-15 |
| WO1998003511A1 (en) | 1998-01-29 |
| BG102707A (en) | 1999-09-30 |
| HRP970395A2 (en) | 1998-08-31 |
| SK114498A3 (en) | 1999-02-11 |
| AU3695597A (en) | 1998-02-10 |
| DE19629378A1 (en) | 1998-01-29 |
| GR3033842T3 (en) | 2000-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0966454T3 (en) | Disubstituted bicyclic heterocycles, their preparation and their use as drugs | |
| NO991815D0 (en) | Oxadiazoles, processes for their preparation and their use as drugs | |
| NO993003L (en) | Sulfonamide derivatives, processes for their preparation and their use as medicaments | |
| DK0740668T3 (en) | Tetracyclic derivatives, processes for their preparation and their use | |
| DK0676409T3 (en) | Erythromycin derivatives, processes for their preparation and their use as pharmaceuticals | |
| DK1095025T3 (en) | Benzimidazoles, their preparation and their use as drugs | |
| DK1083171T3 (en) | Pyrazoline derivatives, their preparation and use as drugs | |
| NO20005146D0 (en) | Thienylazolylalkoxyethanamines, their preparation and their use as drugs | |
| DK1202733T3 (en) | 3 (5) -amino-pyrazole derivatives, process for their preparation and their use as antitumor agents | |
| NO20001409L (en) | Carboxamidothiazole derivatives, processes for their preparation and pharmaceutical compositions | |
| NO963506D0 (en) | 4-Heterocyclyl-substituted quinazoline derivatives, process for their preparation and their use as anti-cancer agents | |
| NO20011503D0 (en) | Indeno-, naphtho- and benzocyclohepta-dihydrotiazole derivatives, their preparation and use as anorectic drugs | |
| NO20006138D0 (en) | Substituted indolinones, preparation and use thereof as drugs | |
| IS2076B (en) | Acyl-piperazinil-pyrimidine derivatives, their preparation and use as pharmaceuticals | |
| DK0770059T3 (en) | Substituted benzamidines, their preparation and their use as drugs | |
| NO981522L (en) | Amino acid derivatives, their preparation and use as endothelin antagonists | |
| DK0912509T3 (en) | Distamycin derivatives, processes for their preparation and their use as antitumor and antiviral agents | |
| DK0903339T3 (en) | Biphenylsulfonyl cyanamide, process for their preparation and their use as a drug | |
| DK0880524T3 (en) | Adenosine antagonists, processes for their preparation and their use as drugs | |
| DK1015433T3 (en) | Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for their preparation and their use as drugs | |
| DK1098891T3 (en) | Polycyclic thiazolidin-2-ylidene amines, process for their preparation and their use as drugs | |
| NO960272D0 (en) | Oxathiolanes, processes for their preparation and pharmaceutical compositions containing the same | |
| DK0727416T3 (en) | Substituted benzenesulfonylureas and thioureas, and process for their preparation, their use as | |
| NO308213B1 (en) | Substituted indanylidinacetylguanidines, their use and drugs containing the compounds | |
| DK1086077T3 (en) | New antiestrogens, methods for their preparation and their pharmaceutical use |